• Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MOR:GR

72.360 EUR 3.150 4.55%

As of 13:55:04 ET on 07/25/2014.

Snapshot for MorphoSys AG (MOR)

Open: 69.500 Day's Range: 69.500 - 72.650 Volume: 200,673
Previous Close: 69.210 52wk Range: 49.455 - 72.720 1-Yr Rtn: +41.72%

Stock Chart for MOR

No chart data available.
  • MOR:GR 72.500
  • 1D
  • 1M
  • 1Y
69.210
Interactive MOR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MOR

Current P/E Ratio (ttm) 240.8333
Estimated P/E(12/2014) -
Relative P/E vs. DAX 13.0743
Earnings Per Share (EUR) (ttm) 0.3000
Est. EPS (EUR) (12/2014) -0.4120
Est. PEG Ratio -
Market Cap (M EUR) 1,900.52
Shares Outstanding (M) 26.30
30 Day Average Volume 53,606
Price/Book (mrq) 5.3847
Price/Sale (ttm) 22.9128
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MOR

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for MOR

MorphoSys AG is a biotechnology company. The Company uses proprietary technology to develop human antibodies tailored to treat specific diseases. MorphoSys is developing medicines to treat cancer and inflammation.

Simon E MoroneyChairman-Mgmt Board/CEOJens HolsteinChief Financial Officer
Marlies SprollChief Scientific OfficerArndt SchotteliusChief Development Officer
More Company Profile & Key Executives for MOR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil